Literature DB >> 24224752

Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitus.

Phillip H Lee1, Andrea S Franks, Patrick B Barlow, Michelle Z Farland.   

Abstract

BACKGROUND: Patients with uncontrolled diabetes are more likely to be readmitted to the hospital. The study objective was to determine the risk of hospital admission or emergency department (ED) use in patients with severely uncontrolled type 2 diabetes mellitus based on whether their diabetes medication regimen was intensified at discharge. SUBJECTS AND METHODS: A retrospective cohort study of patients admitted to the medicine services at an academic medical center was conducted during a 9-month period. Medical records were reviewed to identify patients with type 2 diabetes mellitus and hemoglobin A1c >10% who were admitted for more than 24 h. Primary exclusion criteria included pregnancy, age >65 or <18 years, life expectancy of <12 months, hypoglycemia at admission, and new diagnosis of type 2 diabetes. Admission medication lists for patients were compared with discharge medications to determine whether the diabetes regimen was intensified. Patients whose regimen was intensified were then compared with patients whose regimen was not intensified for admissions and ED visits within 3 months after discharge. The primary end point was 90-day all-cause hospital and ED visits.
RESULTS: Patients who had their regimens intensified had significantly fewer average all-cause hospital and ED visits at 90 days (0.41 vs. 0.85; P=0.044). Statistical differences were also found in 30-day all-cause visits, readmissions within 90 days, and hospital-free time.
CONCLUSIONS: Patients whose home diabetes regimen was intensified at discharge were less likely to return to the hospital within 90 days compared with patients whose regimen was not intensified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24224752     DOI: 10.1089/dia.2013.0168

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  8 in total

1.  Correction to: Hospital Readmission of Patients with Diabetes.

Authors:  Daniel J Rubin
Journal:  Curr Diab Rep       Date:  2018-03-13       Impact factor: 4.810

Review 2.  Hospital readmission of patients with diabetes.

Authors:  Daniel J Rubin
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

Review 3.  Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home.

Authors:  Amy C Donihi
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

Review 4.  The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes.

Authors:  Sherita Hill Golden; Nisa Maruthur; Nestoras Mathioudakis; Elias Spanakis; Daniel Rubin; Mihail Zilbermint; Felicia Hill-Briggs
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

5.  Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers.

Authors:  Alyson K Myers; Makeda Dawkins; Inthuja Baskaran; Stephanie Izard; Meng Zhang; Aditya A Bissoonauth; Sally Kaplan; Amit Rao; Mohammad Elzanaty; Alisha Oropallo
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

6.  Sex differences in glycemic measures, complications, discharge disposition, and postdischarge emergency room visits and readmission among non-critically ill, hospitalized patients with diabetes.

Authors:  Neeti Patel; Janya Swami; Diana Pinkhasova; Esra Karslioglu French; Deborah Hlasnik; Kristin Delisi; Amy Donihi; Linda Siminerio; Daniel J Rubin; Li Wang; Mary T Korytkowski
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

Review 7.  Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life.

Authors:  Denise Soltow Hershey
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec

8.  Emergency department visits of older adults within 30 days of discharge: analysis from the pharmacotherapy perspective.

Authors:  Fabiana Silvestre Dos Santos; Bianca Menezes Dias; Adriano Max Moreira Reis
Journal:  Einstein (Sao Paulo)       Date:  2019-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.